Epidemiology and etiology of overactive bladder;Epidemiologie und ätiologie der instabilen blase

Urologe - Ausgabe A

Volumn 42, Issue 6, 2003, Pages 776-786

  Hampel, C ^a   Gillitzer, R ^b   Pahernik, S ^b   Hohenfellner, M ^b   Thuroff J W ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NONE

Author keywords

Epidemiology; Incontinence; Overactive bladder; Prevalence; Urge

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT;

AGING; ARTICLE; BLADDER NECK STENOSIS; BLADDER STONE; BLADDER TUMOR; DEMOGRAPHY; DETRUSOR MUSCLE; DIABETES MELLITUS; DIAGNOSTIC TEST; DRUG EFFECT; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INCONTINENCE; OVERACTIVE BLADDER; PREVALENCE; QUALITY OF LIFE; SIDE EFFECT; SOCIOECONOMICS; SPINAL CORD INJURY; SYMPTOMATOLOGY; URINARY TRACT INFECTION; URINARY URGENCY;

EID: 0038608534     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0360-1     Document Type: Article

References (19)

1. Abrams P, Blaivas JG, Stanton S, Andersen JT (1988) ICS standardisation of terminology of lower urinary tract function. Neurourol Urodyn 7: 403-26
2. Abrams P, Cardozo L, Fall M et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 21: 167-78
3. Brown JS, McGhan WF, Chokroverty S (2000) Comorbidities associated with overactive bladder. Am J Manag Care 6 (11 Suppl): 574-579
4. Diokno AC, Brock BM, Brown MB, Herzog AR (1986) Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136/5: 1022-1025
5. Elbadawi A,Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol 150/5: 1668-1680
6. Elbadawi A, Diokno AC, Millard RJ (1998) The aging bladder: morphology and urodynamics. World J Urol 16 (Suppl 1): 10-34
7. Elving LB, Foldspang A, Lam GW, Mommsen S (1989) Descriptive epidemiology of urinary incontinence in 3,100 women age 30-59. Scand J Urol Nephrol Suppl 125: 37-43
8. Garnett S, Abrams P (2003) The natural history ofthe overactive bladder ana detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder. J Urol 169/3: 843-848
9. de Groat WC (1997) A neurologic basis for the overactive bladder. Urology 50 (6A Suppl): 36-52; discussion 53-56
10. Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW (1997) Definition of overactive bladder and epidemiology of urinary incontinence. Urology 50 (6A Suppl): 4-14; discussion 1S-17
11. Lapitan MC,Chye PL (2001) The epidemiology of overactive bladder among females in Asia: a questionnaire survey. Int Urogynecol J Pelvic Floor Dysfunct 12/4: 226-231
12. Madersbacher H (1991) Harndrang- und Reflexinkontinenz. Urologe A 30/4: 215-222
13. Meyhoff HH, Gerstenberg TC, Nordling J (1983) Placebo - the drug ofchoice in female motor urge incontinence? BJU 55/1: 34-37
14. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87/9: 760-766
15. Society IC (1976) First report on the standardisation of terminology of lower urinary tract function. BJU 48: 39-42
16. Thomas TM, Plymat KR, Blannin J, Meade TW (1980) Prevalence of urinary incontinence. Br Med J 281 (6250): 1243-1245
17. Voelker R (1998) International group seeks to dispel incontinence "taboo". JAMA 280/11: 951-953
18. Wagner TH, Hu TW (1998) Economic costs of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 9/3: 127-128
19. Wein AJ, Rovner ES (2002) Definition and epidemiology of overactive bladder. Urology 60 (5 Suppl 1): 7-12; discussion 12